Literature DB >> 6418769

Fibronectin in blood products--an in vitro and in vivo study.

J T Reilly, B A McVerry, M J Mackie.   

Abstract

The concentration of fibronectin was assessed in a variety of coagulation factor preparations. Highest concentrations of fibronectin were found in the intermediate purity factor VIII concentrates. Significant amounts were found in cryoprecipitate but high purity factor VIII concentrates contained only small amounts. For practical purposes factor IX concentrates contained no fibronectin. Qualitative estimation of fibronectin showed the presence of an abnormal slow migrating peak on 2 DIEP which was not found in normal plasma. In vivo recovery infused fibronectin was relatively low for all products studied (30-54%). The plasma half life (17-25 h) did not differ significantly depending on whether cryoprecipitate or a factor VIII concentrate was used as a source of fibronectin. No enhancement of plasma fibronectin concentrations was obtained following DDAVP infusion, venous occlusion and exercise. Plasma fibronectin concentrations and 2 DIEP patterns were unaltered following prolonged storage.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418769      PMCID: PMC498572          DOI: 10.1136/jcp.36.12.1377

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.

Authors:  E Engvall; E Ruoslahti
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

2.  Disturbances in circulating opsonic activity in man after operative and blunt trauma.

Authors:  W A Scovill; T M Saba; J E Kaplan; H R Bernard; S R Powers
Journal:  J Surg Res       Date:  1977-06       Impact factor: 2.192

3.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

4.  Sequential changes of plasma proteins after surgical trauma.

Authors:  K F Aronsen; G Ekelund; C O Kindmark; C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

5.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

6.  Blood volume measurement: a critical study prediction of normal values: controlled measurement of sequential changes: choice of a bedside method.

Authors:  F J Dagher; J H Lyons; D C Finlayson; J Shamsai; F D Moore
Journal:  Adv Surg       Date:  1965

7.  Health of the intensively treated hemophiliac, with special reference to abnormal liver chemistries and splenomegaly.

Authors:  P H Levine; B A McVerry; B Attock; K M Dormandy
Journal:  Blood       Date:  1977-07       Impact factor: 22.113

8.  Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation.

Authors:  D F Mosher; E M Williams
Journal:  J Lab Clin Med       Date:  1978-05

9.  Low-grade intravascular coagulation and reticuloendothelial function.

Authors:  J E Kaplan; T M Saba
Journal:  Am J Physiol       Date:  1978-04

10.  Deficits in reticuloendothelial humoral control mechanisms in patients after trauma.

Authors:  W A Scovill; T M Saba; J E Kaplan; H Bernard; S Powers
Journal:  J Trauma       Date:  1976-11
View more
  6 in total

1.  Optimization of the technique of cell migration from explants: Application to human synoviocytes on cryoprecipitate coating.

Authors:  T Ponge; S Cottin; M Collette; J Leveau; J Letenneur
Journal:  Cytotechnology       Date:  1989-05       Impact factor: 2.058

2.  Factor VIII concentrate as a source of fibronectin for replacement therapy.

Authors:  J K Smith; R A Brown; D K Harvey; M J Harvey
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

3.  Fibronectin contributes to pathological cardiac hypertrophy but not physiological growth.

Authors:  Mathias H Konstandin; Mirko Völkers; Brett Collins; Pearl Quijada; Mercedes Quintana; Andrea De La Torre; Lucy Ormachea; Shabana Din; Natalie Gude; Haruhiro Toko; Mark A Sussman
Journal:  Basic Res Cardiol       Date:  2013-08-04       Impact factor: 17.165

4.  Differences between plasma and synovial fluid fibronectin.

Authors:  D L Scott; S D Carter; J S Coppock; M Robinson; K W Walton
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

5.  Double cryoprecipitated factor VIII concentrate from heparinised plasma and its heat treatment.

Authors:  C T Smit Sibinga; P J Schulting; J Notebomer; P C Das; J Marrink; J vd Meer
Journal:  Blut       Date:  1988-03

6.  Interaction of Bartonella henselae with Fibronectin Represents the Molecular Basis for Adhesion to Host Cells.

Authors:  Diana J Vaca; Arno Thibau; Matthias S Leisegang; Johan Malmström; Dirk Linke; Johannes A Eble; Wibke Ballhorn; Martin Schaller; Lotta Happonen; Volkhard A J Kempf
Journal:  Microbiol Spectr       Date:  2022-04-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.